• MoalifePlus
• Baropharm
• GCGenome
• phamedaily

Rookie Baropharm and Embattled Moalife Plus Face Paradoxical Volatility as GC Genome Anchors Mark...

• 유진희
• 2026.11.14
• 오전 06:45

MedPacto Hits Limit-Up on Cancer Drug Data, Curiosis Rebounds on ODM Hopes[K-Bio Pulse]

• 손민지
• 2026.11.12
• 오전 07:35

Samil Pharm hits upper limit...Voronoi jumps 15%[K-bio Pulse]

• 김승권
• 2026.11.11
• 오전 06:00

Vaxcell-bio Soars; Seegene, Alteogen Plunge [K-bio pulse]

• 김진수
• 2026.11.10
• 오전 07:10

Aribio Lab Surges on Merger Speculation; Seers, InBody Plunge on Earnings[K-Bio Pulse]

• 김새미
• 2026.11.07
• 오전 08:38

NGenBio Hits Limit; Financing Splits Proteina, AdBioTech[K-Bio Pulse]

• 김새미
• 2026.11.06
• 오전 07:50

• 팜이데일리
• HLB
• 휴젤
• 레티보
• 아리바이오홀딩스

HLB Shares Plunge as AriBio Surges[K-Bio Pulse]

• 나은경
• 2026.11.05
• 오전 08:10

SK Biopharm’s Xcopri Launches in Korea With Insurance Coverage[K-Bio Pulse]

• 김지완
• 2026.11.04
• 오전 07:15

• iCure
• Daewon
• HLB
• phamedaily

Defying the Market Downturn: HLB and Daewon Pharmaceutical Surge on Earnings Growth Expectations ...

• 유진희
• 2026.11.02
• 오전 06:00

CellBion Gains on Renewed Interest in Prostate Cancer Data; Hanmi Pharma Rises 5% on Obesity Drug...

• 손민지
• 2026.10.30
• 오전 07:05